Q Fever News and Research

RSS

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose.

22 Apr 2019

As syphilis invades rural America, a fraying health safety net is failing to stop it

When Karolyn Schrage first heard about the "dominoes gang" in the health clinic she runs in Joplin, Mo., she assumed it had to do with pizza.

19 Apr 2019

Study: Measles outbreaks may become more frequent if vaccination rates continue to decline

In 2000, measles was declared to be eliminated in the United States, when no sustained transmission of the virus was seen in this country for more than 12 months.

19 Apr 2019

Europe under major threat from vector-borne diseases

Researchers presenting at ECCMID have warned that vector-borne diseases are on the rise and threatening to spread into many parts of Europe.

From ESCMID 15 Apr 2019

Researchers develop novel recombinant vaccine against Nipah virus

Nipah virus is a type of RNA virus transmitted from animals to humans. The infection causes severe respiratory illness and symptoms including cough, headache and fever, which can progress into encephalitis, seizure and coma.

15 Apr 2019

Geographical range of vector-borne diseases expands rapidly, shows research

New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Amsterdam, Netherlands shows that the geographical range of vector-borne diseases such as chikungunya, dengue fever, leishmaniasis, and tick-borne encephalitis is expanding rapidly.

15 Apr 2019

Researchers describe a case of tick-borne relapsing fever in Mexico

Tick-Borne Relapsing Fever is a recurring fever caused by exposure to infected Borrelia bacteria.

12 Apr 2019

German Research Foundation recently approves new research unit

"Cytomegalovirus, beware of this new research group!" This could be the motto of a new research unit recently approved by the German Research Foundation. It is titled: "Advanced concepts in cellular control of cytomegalovirus ".

11 Apr 2019

Maryland researchers find four bat lineages that exhibit extreme longevity

University of Maryland researchers analyzed an evolutionary tree reconstructed from the DNA of a majority of known bat species and found four bat lineages that exhibit extreme longevity.

11 Apr 2019

New study provides overview of potential risks of vaccinating breastfeeding women

In light of the continuing anti-vaccination movement, a provocative new article provides a comprehensive overview of the potential risks of vaccinating breastfeeding women.

11 Apr 2019

Why hay fever persists, despite low pollen counts

A team of researchers are investigating why despite low forecasts of pollen counts, on some days, there is a higher incidence of hay fever.

10 Apr 2019

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.

9 Apr 2019

Acetaminophen can limit positive empathy for others, study shows

A new study by an Ohio University faculty member showed that acetaminophen limited positive empathy a person has for others while taking it.

8 Apr 2019

New study reveals five facts about allergies to vaccines

There is little chance you are actually allergic to vaccines and, if you are, your allergist can give it to you. Only one in 760,000 vaccinations will respond with anaphylaxis. For all other side effects, there are ways around any problem.

8 Apr 2019

Candida auris – a dangerous drug resistant fungi on the rise

Candida auris – a fungus, is one of the newest organisms to plague humans with its resistant nature. It is as present resistant to the available antifungal agents and is emerging as a threat around the world.

8 Apr 2019

ASCO issues guideline recommending older adults with cancer to receive geriatric assessment

Although the majority of patients who have blood cancers are older adults, they make up only a small percentage of participants in the clinical trials that lead to new therapies.

8 Apr 2019

Multistate E. coli outbreak says CDC

The Centers for Disease Control and Prevention (CDC) is looking at a Shiga toxin-producing Escherichia coli outbreak that has spilled across state borders to affect people living in at least five states.

7 Apr 2019

FDA extends indication of metastatic breast cancer treatment to include male patients

The U.S. Food and Drug Administration today is extending the indication of Ibrance (palbociclib) capsules in combination with specific endocrine therapies for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in male patients.

5 Apr 2019

Bronchiectasis patients often display high sensitivity to airborne allergens

An international research team led by Nanyang Technological University, Singapore (NTU Singapore) has found that patients with the lung disease bronchiectasis also often display sensitivity to airborne allergens, and has highlighted the particular role that fungi appear to play.

4 Apr 2019

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.

4 Apr 2019

Q Fever News and Research

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

As syphilis invades rural America, a fraying health safety net is failing to stop it

Study: Measles outbreaks may become more frequent if vaccination rates continue to decline

Europe under major threat from vector-borne diseases

Researchers develop novel recombinant vaccine against Nipah virus

Geographical range of vector-borne diseases expands rapidly, shows research

Researchers describe a case of tick-borne relapsing fever in Mexico

German Research Foundation recently approves new research unit

Maryland researchers find four bat lineages that exhibit extreme longevity

New study provides overview of potential risks of vaccinating breastfeeding women

Why hay fever persists, despite low pollen counts

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

Acetaminophen can limit positive empathy for others, study shows

New study reveals five facts about allergies to vaccines

Candida auris – a dangerous drug resistant fungi on the rise

ASCO issues guideline recommending older adults with cancer to receive geriatric assessment

Multistate E. coli outbreak says CDC

FDA extends indication of metastatic breast cancer treatment to include male patients

Bronchiectasis patients often display high sensitivity to airborne allergens

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Latest News